Citigroup
C
Bank of America
BAC
Apple
AAPL
4
American Express
AXP
5
Chevron
CVX
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.610
- +0.028+4.83%
Close Feb 14 16:00 ET
- 0.602
- -0.008-1.33%
Post 19:52 ET
178.25MMarket Cap-0.77P/E (TTM)
0.625High0.588Low1.76MVolume0.605Open0.582Pre Close1.07MTurnover0.81%Turnover RatioLossP/E (Static)292.16MShares3.25652wk High0.34P/B132.11MFloat Cap0.50952wk Low--Dividend TTM216.54MShs Float19.840Historical High--Div YieldTTM6.34%Amplitude0.509Historical Low0.609Avg Price1Lot Size
Lyell Immunopharma News
Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(3.93%)
Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(3.93%)
Lyell Immunopharma | 3: Initial statement of beneficial ownership of securities-Director Ramachandra Sumant
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Ramachandra Sumant
Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-James Tananbaum (“Tananbaum”)(5.3%),Foresite Capital Fund IV, L.P. (“FCF IV”)(3.2%), etc.
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY
Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lang Matthew
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Newton Charles W.
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn
Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)
Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now